Skip to main content

Table 3 Autonomic Symptom Profile Scores, score > 0, n (%).

From: Autonomic neuropathy in Fabry disease: a prospective study using the Autonomic Symptom Profile and cardiovascular autonomic function tests

Domain

All patients

n = 48

non-ERT

n = 18

ERT

n = 30

non-ERT versus ERT, p-value

Healthy controls

n = 48

Patients versus controls, p-value

Orthostatic intolerance

36 (75)

13 (72)

23 (77)

0.74

24 (50)

0.02

Vasomotor impairment

15 (31)

4 (22)

11 (37)

0.35

6 (13)

0.047

Secretomotor disorder

28 (58)

3 (17)

25 (83)

0.00

25 (52)

0.68

Gastroparesis

15 (31)

4 (22)

11 (37)

0.35

6 (13)

0.047

Diarrhoea

13 (27)

6 (33)

7 (23)

0.51

15 (31)

0.82

Constipation

10 (21)

4 (22)

6 (20)

1.00

14 (29)

0.48

Bladder disorder

17 (35)

5 (28)

12 (40)

0.54

18 (38)

1.00

Pupillomotor impairment

29 (60)

12 (67)

17 (57)

0.55

19 (40)

0.07

Sleep disorder

28 (58)

5 (28)

23 (77)

0.00

23 (48)

0.41

Syncope

3 (6)

2 (11)

1 (3)

0.55

1 (2)

0.62

Sum score

46 (96)

17 (94)

29 (97)

1.00

46 (96)

1.00

 

Male patients

n = 15

non-ERT

n = 2

ERT

n = 13

p-value

Male controls

n = 15

p-value

Male sexual failure

6 (40)

1 (50)

5 (38)

1.00

3 (20)

0.43

  1. ERT = enzyme replacement therapy